Radcliffe Group Appoints Dr. Peter O’Kane New Editor-in-Chief of Interventional Cardiology Review and Opens Journal to Original Research Through Its Title Change (ICR3)

Radcliffe Group, a STM publisher and digital media producer of cardiovascular, renal, and metabolic content has announced Dr. Peter O’Kane as the new editor-in-chief of their journal, Interventional Cardiology: Reviews, Research, and Resources.

Dr. O’Kane was appointed as a consultant interventional cardiologist at the Royal Bournemouth Hospital in July 2007 and has performed more than 7,000 PCI cases. He has extensive experience with coronary physiology and intra-coronary imaging to guide intervention and the many tools and techniques to manage bifurcations, calcification, and chronic occlusions.

He is committed to teaching and has trained many physicians both in the UK and internationally in devices such as rotational and laser atherectomy and developing technical skills such as those involved in bifurcation stenting and coronary imaging utilization. He has presented at many cardiology conferences and performed as a live case operator. He has contributed to 30 global research studies as a local principal investigator with a high provision of randomized patients and has co-authored more than 50 manuscripts in addition to 10 book chapters.

With such a keen interest in clinical and academic cardiology, Dr. O’Kane is very excited to take this position. “It is a great privilege to accept the position of EiC for ICR3 and work alongside a fantastic team of clinicians, academics, and editors in this well-established publishing house. I will bring my cardiology experience to build on the strong foundations of the journal and develop strategies to promote original research submission whilst maintaining the recognized high quality of reviews and clinical resources that have been synonymous with Radcliffe Group and have undoubtedly guided patient care across the world”, said Dr. O’Kane.

Radcliffe Cardiology would like to thank Dr. Simon Kennon for his editorship of ICR over the last seven years and wish him well. He will continue to remain involved with the ICR journal as an editorial board member, supporting the incumbent Editor-in-Chief.

At the same time, ICR is changing its title to Interventional Cardiology: Reviews, Research, Resources (ICR3) and has now opened to receive submissions of original research. This is the next step in the journal’s development, and we are thrilled about the exciting opportunities to come.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.